Mark A. Yorek
Impact in
- Clinical Biochemistry top 0.05%
- Advanced Glycation End Products research
- Physiology top 0.2%
- Pain Mechanisms and Treatments
- Adipose Tissue and Metabolism
- Biochemical effects in animals
Papers in
-
- Advanced Glycation End Products research 22
- Physiology 88
- Pain Mechanisms and Treatments 33
- Biochemical effects in animals 22
- Nitric Oxide and Endothelin Effects 15
- Co-authors
- A A SpectorLawrence J. CoppeyEric P. DavidsonJoyce A. DunlapWilliam I. SivitzTakeshi MatsumuraTakeshi NishikawaXue Du
- Journals
- Diabetes (13 papers)Journal of Neurochemistry (13 papers)Biochimica et Biophysica Acta (BBA) - General Subjects (6 papers)Metabolism (6 papers)European Journal of Pharmacology (4 papers)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Mark A. Yorek
166 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Clinical Biochemistry 2.2k
- Physiology 4.1k
- Biochemistry 964
- Endocrinology, Diabetes and Metabolism 2.0k
- Neurology 715
Countries citing papers authored by Mark A. Yorek
This map shows the geographic impact of Mark A. Yorek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Yorek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Yorek more than expected).
Fields of papers citing papers by Mark A. Yorek
This network shows the impact of papers produced by Mark A. Yorek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Yorek. The network helps show where Mark A. Yorek may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Yorek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2017 | 26 | |
| 3 | 2016 | 20 | |
| 4 | 2016 | 14 | |
| 5 | Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic rats | 2015 | 1 |
| 6 | 2015 | 29 | |
| 7 | 2012 | 51 | |
| 8 | Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities Hit paper breakdown → | 2009 | 581 |
| 9 | 2007 | 20 | |
| 10 | 2007 | 105 | |
| 11 | 2006 | 16 | |
| 12 | 2003 | 175 | |
| 13 | 2001 | 63 | |
| 14 | 1999 | 10 | |
| 15 | 1996 | 24 | |
| 16 | 1993 | 4 | |
| 17 | 1992 | 20 | |
| 18 | 1992 | 7 | |
| 19 | 1990 | 1 | |
| 20 | 1989 | 17 |
About Mark A. Yorek
Mark A. Yorek is a scholar working on Clinical Biochemistry, Physiology, Neurology, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 168 papers that have together received 11.0k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (33 papers), Biochemical effects in animals (22 papers), Advanced Glycation End Products research (22 papers), Fatty Acid Research and Health (20 papers), Neurological Disorders and Treatments (18 papers), Aldose Reductase and Taurine (17 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (15 papers) and Nitric Oxide and Endothelin Effects (15 papers). The work is most often cited by research in Clinical Biochemistry (2.2k citations), Physiology (4.1k citations), Biochemistry (964 citations), Endocrinology, Diabetes and Metabolism (2.0k citations) and Neurology (715 citations). Mark A. Yorek has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include A A Spector, Lawrence J. Coppey, Eric P. Davidson, Joyce A. Dunlap, William I. Sivitz, Takeshi Matsumura, Takeshi Nishikawa, Xue Du, Ida Giardino and Diane Edelstein. Their work appears in journals such as Diabetes, Journal of Neurochemistry, Biochimica et Biophysica Acta (BBA) - General Subjects, Metabolism and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.